BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 6277644)

  • 1. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
    Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
    J Pharmacol Exp Ther; 1981 Nov; 219(2):296-8. PubMed ID: 6116798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modification of opiate receptor activity by arylsulfatase treatment.
    Garzón J; Jen MF; Lee NM
    Biochem Pharmacol; 1983 May; 32(9):1523-8. PubMed ID: 6134534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-induced hyperthermia: lack of cross-tolerance with enkephalin analogs.
    Clark WG; Bernardini GL
    Brain Res; 1982 Jan; 231(1):231-4. PubMed ID: 6275948
    [No Abstract]   [Full Text] [Related]  

  • 5. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL; Rothman RB; Westfall TC
    Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin (1-13): analgesia, hypothermia, cross-tolerance with morphine and beta-endorphin.
    Petrie EC; Tiffany ST; Baker TB; Dahl JL
    Peptides; 1982; 3(1):41-7. PubMed ID: 6281745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of opioid peptides on respiration and analgesia in rats.
    Flórez J; Pazos A
    Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
    Jhamandas K; Sutak M
    Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic activity of intracerebroventricular administration of morphiceptin and beta-casomorphins: correlation with the morphine (micro) receptor binding affinity.
    Chang KJ; Cuatrecasas P; Wei ET; Chang JK
    Life Sci; 1982 May; 30(18):1547-51. PubMed ID: 6281604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of naloxone, morphine, and an enkephalin analogue on cholecystokinin octapeptide-stimulated gallbladder emptying.
    Worobetz LJ; Baker RJ; McCallum JA; Wells G; Sullivan SN
    Am J Gastroenterol; 1982 Jul; 77(7):509-11. PubMed ID: 6283883
    [No Abstract]   [Full Text] [Related]  

  • 13. Opiate and peptide interaction: effect of enkephalins on morphine analgesia.
    Lee NM; Leybin L; Chang JK; Loh HH
    Eur J Pharmacol; 1980 Nov; 68(2):181-5. PubMed ID: 6258928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Yajima F; Suda T; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    Life Sci; 1986 Jul; 39(2):181-6. PubMed ID: 2873496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological evidence for kappa-agonist activity of dynorphin in rat brain.
    Brookes A; Bradley PB
    Neuropharmacology; 1984 Feb; 23(2A):207-10. PubMed ID: 6325991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motility effects of opioid peptides in dog intestine.
    Burks TF; Hirning LD; Galligan JJ; Davis TP
    Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to morphine-evoked bradycardia in rats is modified by dynorphin (1-13), Leu- and Met-enkephalin.
    Kiang JG; Wei ET
    J Pharmacol Exp Ther; 1984 May; 229(2):469-73. PubMed ID: 6716269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractile effect of morphine and related opioid alkaloids, beta-endorphin and methionine enkephalin on the isolated colon from Long Evans rats.
    Huidobro-Toro JP; Way EL
    Br J Pharmacol; 1981 Nov; 74(3):681-94. PubMed ID: 6170377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of opioid peptides on peripheral blood granulocytes].
    Pasotti D; Mazzone A; Lecchini S; Frigo GM; Ricevuti G
    Riv Eur Sci Med Farmacol; 1993; 15(2):71-81. PubMed ID: 7909619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.